| AMINOLEVULINIC ACID HYDROCHLORIDE | DUSA PHARMACEUTICALS, INC | ||
| 20%; Solution, Topical |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
|
Less Than 5
|
None | ||
| None | None | ||
| Indicated for the treatment of minimally to moderately thick actinic keratoses of the face, scalp, or upper extremities. | |||
|
Yes
| |||
| LEVULAN | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *********** *** | ******* | ******* | *** ********* (***** ******) | *** ********* (***** ******) | *** ********* (***** ******) | *** ********* (***** ******) | *** ********* (***** ******) | *** ********* (***** ******) | *** ********* (***** ******) / **** - *** ****** | *** ********* (***** ******) | *** ********* (***** ******) | *** ********* (***** ******) |
| ******* *** ************ ******* | ******* *** ************ ******* | ******* *** ************ ******* | ****** ** ************* *-************** **** (***) ** * ******* | ********** *********** *** ************ ******* *** ********* | ******* *** ************ ******* | ******* *** ************ ******* | ********** *********** *** ************ ******* *** ********* | ********** *********** *** ************ ******* *** ********* | ******* *** ************ ******* | *********** *** ************ ******* | *********** *** ************ ******* |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| *********** *** | *** / ** | *** ** **** | ******* | **** | ****** **** ******** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|